KD Logo

Evolent Health Inc [EVH] stock was sold by McCarthy Daniel Joseph at the price of US$0.73 million

In a filing, Evolent Health Inc revealed its PRESIDENT McCarthy Daniel Joseph unloaded Company’s shares for reported $0.73 million on Aug 22 ’24. In the deal valued at $30.89 per share,23,693 shares were sold. As a result of this transaction, McCarthy Daniel Joseph now holds 198,809 shares worth roughly $2.53 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, McCarthy Daniel Joseph sold 10,469 shares, generating $339,008 in total proceeds. Upon selling the shares at $32.38, the PRESIDENT now owns 188,340 shares.

Before that, Weinberg Jonathan sold 42,140 shares. Evolent Health Inc shares valued at $1,314,706 were divested by the General Counsel at a price of $31.20 per share. As a result of the transaction, Weinberg Jonathan now holds 167,027 shares, worth roughly $2.12 million.

Stephens downgraded its Evolent Health Inc [EVH] rating to an Equal-weight from a an Overweight in a research note published on November 08, 2024; the price target was decreased to $16 from $38. A number of analysts have revised their coverage, including KeyBanc Capital Markets’s analysts, who began to cover the stock in mid October with a ‘”an Overweight”‘ rating. Truist also remained covering EVH and has increased its forecast on August 09, 2024 with a “Buy” recommendation from previously “Hold” rating. Citigroup started covering the stock on April 22, 2024. It rated EVH as “a Buy”.

Price Performance Review of EVH

On Monday, Evolent Health Inc [NYSE:EVH] saw its stock fall -1.63% to $12.71. Over the last five days, the stock has gained 12.98%. Evolent Health Inc shares have fallen nearly -61.52% since the year began. Nevertheless, the stocks have fallen -54.28% over the past one year. While a 52-week high of $35.00 was reached on 03/04/24, a 52-week low of $11.17 was recorded on 11/21/24. SMA at 50 days reached $21.46, while 200 days put it at $25.57.

Levels Of Support And Resistance For EVH Stock

The 24-hour chart illustrates a support level at 12.56, which if violated will result in even more drops to 12.41. On the upside, there is a resistance level at 12.92. A further resistance level may holdings at 13.13. The Relative Strength Index (RSI) on the 14-day chart is 31.98, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.37, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 64.92%. Stochastics %K at 38.34% indicates the stock is a holding.

How much short interest is there in Evolent Health Inc?

A steep rise in short interest was recorded in Evolent Health Inc stocks on 2024-11-15, dropping by 78092.0 shares to a total of 10.82 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 10.9 million shares. There was a decline of -0.72%, which implies that there is a negative sentiment for the stock.

The most recent change occurred on March 01, 2024 when Oppenheimer began covering the stock and recommended ‘”an Outperform”‘ rating along with a $45 price target.

Most Popular